LRMR Stock-Based Compensation

Larimar Therapeutics Inc · Stock-Based Compensation

LRMR logo

LRMR Stock-Based Compensation

Latest reported$2.15M
LRMR Quarterly Stock-Based Comp ($1.06M → $2.15M)
High-resolution chart · PNG

LRMR stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Larimar Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
2,149,000
1,979,000
1,557,000
1,785,000
1,828,000
1,834,000
2,410,000
1,957,000
2,301,000
2,128,000
1,918,000
1,821,000
2,043,000
1,833,000
1,643,000
1,666,000
1,675,000
1,635,000
1,480,000
1,463,000
1,350,000
1,180,000
1,010,000
370,000
752,000
29,000
0
33,000
33,000
34,000
7,161,000
0
2,466,000
-2,001,000
2,001,000
-2,756,000
2,756,000
7,525,000
1,057,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.